Agios Pharmaceuticals, Inc. United States of America (USA)

Research

Date range: 1 June 2022 - 31 May 2023

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Agios Pharmaceuticals, Inc. published between 1 June 2022 - 31 May 2023 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Agios Pharmaceuticals, Inc.
Count Share
4 1.00

Outputs by subject (Share)

Outputs by subject
Subject Count Share
1 0.07
1 0.07
3 0.94

Share output for the past 5 years

Share per year
2018 2019 2020 2021 2022*
1.64 1.92 0.61 1.36 1.57

Compare Agios Pharmaceuticals, Inc. with other institutions

*Note: 2022 data contains Share for article affiliations from newly added health-science journals.

Nature Strategy Reports

Nature Strategy Reports gives you simple insights to support decisions that impact your organisation

The reports created for you by our subject matter experts combine compelling insights with Nature’s trust and authority. Get an in-depth analysis of your and your peers’ research performance, including a breakdown of relative strengths and weaknesses. All of which is crafted using data and tools from across Nature Research Intelligence, covering all major disciplines and all regions of the world.

Collaboration

Date range: 1 June 2022 - 31 May 2023

International vs. domestic collaboration by Share

  • 33.67% Domestic (9 institutions)
  • 66.33% International (30 institutions)

Hover over the graph to view the percentage of collaboration.


Top 10 domestic collaborators with Agios Pharmaceuticals, Inc. by Share*

  1. Agios Pharmaceuticals, Inc. and University of California, San Francisco (UCSF) (1.05)
    Agios Pharmaceuticals, Inc.0.75
    University of California, San Francisco (UCSF)0.30
  2. Agios Pharmaceuticals, Inc. and Harvard University (0.95)
    Agios Pharmaceuticals, Inc.0.75
    Harvard University0.20
  3. Agios Pharmaceuticals, Inc. and Servier Pharmaceuticals LLC. (0.43)
    Agios Pharmaceuticals, Inc.0.25
    Servier Pharmaceuticals LLC.0.18
  4. Agios Pharmaceuticals, Inc. and University of California, Los Angeles (UCLA) (0.38)
    Agios Pharmaceuticals, Inc.0.25
    University of California, Los Angeles (UCLA)0.13
  5. Agios Pharmaceuticals, Inc. and Memorial Sloan Kettering Cancer Center (MSKCC) (0.35)
    Agios Pharmaceuticals, Inc.0.25
    Memorial Sloan Kettering Cancer Center (MSKCC)0.10
  6. Agios Pharmaceuticals, Inc. and Duke University (0.30)
    Agios Pharmaceuticals, Inc.0.25
    Duke University
  7. Agios Pharmaceuticals, Inc. and The University of Texas Southwestern Medical Center (UT Southwestern Medical Center) (0.30)
    Agios Pharmaceuticals, Inc.0.25
    The University of Texas Southwestern Medical Center (UT Southwestern Medical Center)
  8. Agios Pharmaceuticals, Inc. and Aligos Therapeutics, Inc. (0.28)
    Agios Pharmaceuticals, Inc.0.25
    Aligos Therapeutics, Inc.
  9. Agios Pharmaceuticals, Inc. and California University of Science and Medicine (CUSM) (0.28)
    Agios Pharmaceuticals, Inc.0.25
    California University of Science and Medicine (CUSM)

Top 10 international collaborators with Agios Pharmaceuticals, Inc. by Share*

  1. Agios Pharmaceuticals, Inc. and University of Toronto (U of T) (1.60)
    Agios Pharmaceuticals, Inc.0.57
    University of Toronto (U of T)1.03
  2. Agios Pharmaceuticals, Inc. and Imperial College Healthcare NHS Trust (0.60)
    Agios Pharmaceuticals, Inc.0.50
    Imperial College Healthcare NHS Trust0.10
  3. Agios Pharmaceuticals, Inc. and Assistance Publique-Hôpitaux de Paris (AP-HP) (0.51)
    Agios Pharmaceuticals, Inc.0.19
    Assistance Publique-Hôpitaux de Paris (AP-HP)0.32
  4. Agios Pharmaceuticals, Inc. and Institute Gustave-Roussy (IGR) (0.37)
    Agios Pharmaceuticals, Inc.0.19
    Institute Gustave-Roussy (IGR)0.18
  5. Agios Pharmaceuticals, Inc. and Contrôle Transcriptionnel et Épigénétique de l’Hématopoïèse Maligne (0.28)
    Agios Pharmaceuticals, Inc.0.19
    Contrôle Transcriptionnel et Épigénétique de l’Hématopoïèse Maligne
  6. Agios Pharmaceuticals, Inc. and National Institute for Health and Medical Research (INSERM) (0.26)
    Agios Pharmaceuticals, Inc.0.19
    National Institute for Health and Medical Research (INSERM)
  7. Agios Pharmaceuticals, Inc. and Imagine Institute (0.26)
    Agios Pharmaceuticals, Inc.0.19
    Imagine Institute
  8. Agios Pharmaceuticals, Inc. and University of Gothenburg (GU) (0.25)
    Agios Pharmaceuticals, Inc.0.19
    University of Gothenburg (GU)
  9. Agios Pharmaceuticals, Inc. and Clinique du Diaconat (0.25)
    Agios Pharmaceuticals, Inc.0.19
    Clinique du Diaconat
  10. Agios Pharmaceuticals, Inc. and University of Bordeaux (0.25)
    Agios Pharmaceuticals, Inc.0.19
    University of Bordeaux

*Share is the fractional count allocated to an institution for an article that takes into account the percentage of authors from that institution and the number of affiliated institutions that contributed to the article. The horizontal stacked bar charts above indicate the Share contributed by each institution in the bilateral collaboration. If the Share is not shown, hover over the bar to display it.

Nature Careers

Need to hire scientific researchers?

Nature Careers is visited by over 180,000 active jobseekers per month that you can target directly with your role. Application response rates have increased by 28% on average over 2022 averages.